$Hang Seng Index (800000.HK)$ plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion.
Pharmaceuticals were sold off. $REMEGEN (09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$CLOVER BIO-B (02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $VIVA BIOTECH (01873.HK)$ ...

In FT's story, The commerce department is expected to place more than two dozen Chinese companies on the entity list on Thursday, including some involved in biotechnology.
The news triggers the sell-off in Hong Kong.
$WUXI BIO (02269.HK)$ $WUXI APPTEC (02359.HK)$ $CLOVER BIO-B (02197.HK)$ $REMEGEN (09995.HK)$

$Dynavax Technologies (DVAX.US)$ is the adjuvant for $Valneva (VALN.US)$ and $CLOVER BIO-B (02197.HK)$ vaccine…. they will be real answers to the new variant. Bullish